- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT07426302
Virtual Reality-assisted Cognitive Rehabilitation in Autistic Youth With ADHD
February 16, 2026 updated by: IRCCS Centro Neurolesi Bonino Pulejo
A Randomized Controlled Trial on the Effectiveness of Virtual Reality-assisted Executive Function Training in Autistic and ADHD Youth
This study aims to evaluate the effectiveness of a virtual reality-based intervention using the Virtual Reality Rehabilitation System (VRRS) to improve executive functions in autistic and ADHD youth aged 8 to 18 years.
Executive functions, such as working memory, cognitive flexibility, and inhibitory control, are frequently impaired in individuals with autism and/or ADHD and significantly affect daily functioning.
Participants will be randomly assigned to either an experimental group that receives VRRS-assisted cognitive training or a control group that receives treatment as usual.
The intervention includes gamified tasks within immersive virtual environments specifically designed to stimulate executive skills.
The primary outcome is the change in executive function scores from baseline to post-intervention, assessed using validated neuropsychological instruments.
The study adopts a randomized controlled design.
Study Overview
Status
Enrolling by invitation
Intervention / Treatment
Study Type
Interventional
Enrollment (Estimated)
50
Phase
- Not Applicable
Contacts and Locations
This section provides the contact details for those conducting the study, and information on where this study is being conducted.
Study Locations
-
-
-
Messina, Italy
- Francesca Cucinotta
-
-
Participation Criteria
Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.
Eligibility Criteria
Ages Eligible for Study
- Child
- Adult
Accepts Healthy Volunteers
No
Description
Inclusion Criteria:
- Age between 8 and 18 years at enrollment
- Clinical diagnosis of Autism Spectrum Disorder and Attention- Deficit/Hyperactivity Disorder, based on DSM-5 criteria
- IQ > 70
- Signed Informed consent provided by a parent or legal guardian;
- No acute or chronic medical conditions
Exclusion Criteria:
- Age not between 8 and 18 years at enrollment
- Lack of a clinical diagnosis of Autism Spectrum Disorder or Attention-Deficit/Hyperactivity Disorder
- IQ < 70
- Failure to sign informed consent from a parent or legal guardian;
- Presence of acute or chronic medical conditions
Study Plan
This section provides details of the study plan, including how the study is designed and what the study is measuring.
How is the study designed?
Design Details
- Primary Purpose: Treatment
- Allocation: Randomized
- Interventional Model: Parallel Assignment
- Masking: Single
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
|---|---|
|
Experimental: VRRS Cognitive Training
The intervention consists of 20 individual sessions using the Virtual Reality Rehabilitation System (VRRS).
Each session lasts 45 minutes and is held biweekly.
The project aims to stimulate and improve memory and executive functions, such as planning and attention, in children with ASD and ADHD.
The VRRS platform integrates semi-immersive and interactive cognitive exercises in a virtual environment, increasing engagement and motivation.
Tasks are progressively adapted to the participant's level and performance.
|
VRRS is a virtual reality system designed to offer interactive cognitive exercises in an immersive environment.
Participants will complete 20 sessions (one session per week).
Each session lasts approx
|
|
Active Comparator: Treatment As Usual
Participants in this group will begin traditional CBT intervention without the use of virtual reality technology.
|
Participants will receive the usual care typically provided in clinical or educational settings, such as attention training, memory exercises, or academic support.
The frequency and duration of sessions will be comparable to the experimental group, but without the use of VR technology.
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Leiter-3
Time Frame: T0(baseline)-T1(6months)
|
The Leiter-3 is a nonverbal, standardized cognitive assessment tool designed to evaluate intellectual functioning, attention, and memory in children and adolescents.
In this study, selected subtests from the Leiter-3 will be used not only to estimate nonverbal IQ, but also to assess attentional control and memory capacity at both baseline and post-intervention.
Administering the Leiter-3 at T0 and T1 allows for the comparison of pre- and post-intervention cognitive functioning without the confounding effects of language.
Scaled scores from the Reasoning, Attention/Memory, and Processing Speed subdomains will be analyzed.
|
T0(baseline)-T1(6months)
|
|
Tower of London
Time Frame: T0(baseline)-T1(6months)
|
The Tower of London (ToL) is a standardized neuropsychological test used to assess higher-order executive functions, particularly planning, problem-solving, and working memory.
|
T0(baseline)-T1(6months)
|
|
NEPSY-II
Time Frame: T0(baseline)-T1(6months)
|
Subtests from the NEPSY-II (e.g., Auditory Attention and Response Set, Inhibition) will be administered to evaluate selective attention, sustained attention, cognitive flexibility, and the ability to shift between task demands.
These measures are developmentally appropriate and widely used to detect attentional and executive control difficulties in children and adolescents with neurodevelopmental conditions.
|
T0(baseline)-T1(6months)
|
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Conners Rating Scales
Time Frame: T0(baseline)-T1(6months)
|
The Conners Rating Scales are validated questionnaires completed by caregivers and/or teachers to assess symptoms of inattention, hyperactivity, and impulsivity, as well as related behavioral concerns.
|
T0(baseline)-T1(6months)
|
|
Child Behavior Checklist (CBCL)
Time Frame: T0(baseline)-T1(6months)
|
The CBCL is a caregiver-completed behavioral inventory used to identify emotional and behavioral problems in children.
It includes internalizing and externalizing behavior subscales and is a standardized tool for tracking psychological and behavioral changes over time in children with ASD and ADHD.
T-scores will be used for analysis.
|
T0(baseline)-T1(6months)
|
|
Short Sensory Profile (SSP)
Time Frame: T0(baseline)-T1(6months)
|
The SSP is a caregiver-reported tool used to identify atypical sensory processing patterns in children.
It provides scores on several sensory domains such as tactile sensitivity, sensory seeking, and auditory filtering.
This instrument is widely used to describe sensory modulation issues in neurodivergent children and track potential improvements following therapeutic interventions.
|
T0(baseline)-T1(6months)
|
|
Repetitive Behavior Scale-Revised (RBS-R)
Time Frame: T0(baseline)-T1(6months)
|
The RBS-R is a caregiver-reported measure of repetitive and restricted behaviors, including stereotypies, compulsions, insistence on sameness, and ritualistic behaviors.
It is frequently used in research on autism to quantify behavioral rigidity and repetitive actions.
Total and subscale scores will be analyzed to determine the impact of the intervention on these behaviors.
|
T0(baseline)-T1(6months)
|
|
Quality of Life in Autism Questionnaire (QoLA)
Time Frame: T0(baseline)-T1(6months)
|
The Quality of Life in Autism Questionnaire (QoLA) is a validated caregiver-report instrument designed to assess autism-specific quality of life.
|
T0(baseline)-T1(6months)
|
Collaborators and Investigators
This is where you will find people and organizations involved with this study.
Investigators
- Principal Investigator: Cucinotta Francesca, CF, IRCCS Neurolesi Bonino Pulejo
Publications and helpful links
The person responsible for entering information about the study voluntarily provides these publications. These may be about anything related to the study.
General Publications
- Yerys BE, Bertollo JR, Kenworthy L, Dawson G, Marco EJ, Schultz RT, Sikich L. Brief Report: Pilot Study of a Novel Interactive Digital Treatment to Improve Cognitive Control in Children with Autism Spectrum Disorder and Co-occurring ADHD Symptoms. J Autism Dev Disord. 2019 Apr;49(4):1727-1737. doi: 10.1007/s10803-018-3856-7.
- Patel K, Curtis LT. A comprehensive approach to treating autism and attention-deficit hyperactivity disorder: a prepilot study. J Altern Complement Med. 2007 Dec;13(10):1091-7. doi: 10.1089/acm.2007.0611.
- Chu L, Shen L, Ma C, Chen J, Tian Y, Zhang C, Gong Z, Li M, Wang C, Pan L, Zhu P, Wu D, Wang Y, Yu G. Effects of a Nonwearable Digital Therapeutic Intervention on Preschoolers With Autism Spectrum Disorder in China: Open-Label Randomized Controlled Trial. J Med Internet Res. 2023 Aug 24;25:e45836. doi: 10.2196/45836.
- Chan JK, Cheung TC, Chan CW, Fang F, Lai KY, Sun X, O'Reilly H, Golan O, Allison C, Baron-Cohen S, Leung PW. Enhancing emotion recognition in young autistic children with or without attention-deficit/hyperactivity disorder in Hong Kong using a Chinese App version of The Transporters. Autism. 2024 Apr;28(4):945-958. doi: 10.1177/13623613231187176. Epub 2023 Jul 31.
- De Domenico C, Alito A, Leonardi G, Pironti E, Di Cara M, Piccolo A, Settimo C, Quartarone A, Gagliano A, Cucinotta F. Children and Adolescents with Co-Occurring Attention-Deficit/Hyperactivity Disorder and Autism Spectrum Disorder: A Systematic Review of Multimodal Interventions. J Clin Med. 2025 Jun 5;14(11):4000. doi: 10.3390/jcm14114000.
Study record dates
These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.
Study Major Dates
Study Start (Actual)
June 1, 2023
Primary Completion (Estimated)
June 30, 2026
Study Completion (Estimated)
July 1, 2026
Study Registration Dates
First Submitted
February 16, 2026
First Submitted That Met QC Criteria
February 16, 2026
First Posted (Actual)
February 23, 2026
Study Record Updates
Last Update Posted (Actual)
February 23, 2026
Last Update Submitted That Met QC Criteria
February 16, 2026
Last Verified
February 1, 2026
More Information
Terms related to this study
Additional Relevant MeSH Terms
Other Study ID Numbers
- VRRS_PLUS
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
No
Studies a U.S. FDA-regulated device product
No
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Autism Spectrum Disorder
-
Fondazione I.R.C.C.S. Istituto Neurologico Carlo...Istituto Clinico HumanitasRecruitingAutism | Autism Spectrum Disorder (ASD) | Autism DisorderItaly
-
The Children's Hospital of Zhejiang University...Not yet recruitingAutism | Autism Spectrum Disorder (ASD)China
-
Poznan University of Physical EducationCompletedAutism | Autism Spectrum Disorder (ASD)Poland
-
Greater Atlanta Integrative PediatricsRecruitingAutism Spectrum Disorder | Autism | ASD | Autism Spectrum Disorder (ASD)United States
-
Adia Med of Winter Park LLCRecruitingAutism Spectrum Disorder | Autism | ASD | Autism Spectrum Disorder (ASD)United States
-
Poznan University of Physical EducationNational Science Centre, PolandCompletedAutism Spectrum Disorder | ASD | Autism Spectrum Disorder High-Functioning | Autism SpectrumPoland
-
Blinklab LimitedRecruitingAutism Spectrum Disorder | Autism | Neurodevelopmental Conditions | Autism Spectrum Disorder (ASD)United States
-
Stanford UniversityJohn and Marcia Goldman FoundationNot yet recruitingAutism | Autism Spectrum Disorder (ASD)United States
-
National Cheng-Kung University HospitalCompletedAutism Spectrum Disorder (ASD) | Autism Spectrum Disorder High-FunctioningTaiwan
-
Stanford UniversityCalifornia Department of Developmental ServicesActive, not recruitingAutism Spectrum Disorder | Autistic Disorder | Autism | Autism Spectrum Disorders | Autistic Disorders Spectrum | Autistic Spectrum Disorder | Autistic Spectrum DisordersUnited States
Clinical Trials on VRRS Cognitive Training
-
Anna EstraneoIstituti Clinici Scientifici Maugeri SpA; Ospedale Policlinico San MartinoRecruitingAcquired Brain InjuryItaly
-
IRCCS Eugenio MedeaCompletedNeurological Diseases or ConditionsItaly
-
Fondazione Don Carlo Gnocchi OnlusIRCCS San Camillo, Venezia, Italy; Istituti Clinici Scientifici Maugeri SpA; IRCCS... and other collaboratorsActive, not recruiting
-
IRCCS Centro San Giovanni di Dio FatebenefratelliIRCCS San Raffaele; Fondazione Don Carlo Gnocchi Onlus; IRCCS Centro Neurolesi...Completed
-
IRCCS Centro Neurolesi "Bonino-Pulejo"Enrolling by invitationIntellectual Disability | Autism Spectrum DisorderItaly
-
IRCCS San Camillo, Venezia, ItalyFondazione Don Carlo Gnocchi Onlus; Istituto Clinico Humanitas; IRCCS San Raffaele... and other collaboratorsCompleted
-
IRCCS Fondazione Stella MarisFondazione Policlinico Universitario Agostino Gemelli IRCCS; Fondazione I.R... and other collaboratorsRecruitingNeurodevelopmental Cognitive, Motor and Speech-language DisabilitiesItaly
-
Science and Research Centre KoperAlbert Einstein College of Medicine; University of Primorska; Vrije Universiteit...CompletedEffects of Cognitive Intervention on Cognition, Mobility and Brain Electrocortical Activity (GIBKOP)Cognitive Impairment | Aging | Cognitive Decline | Motor Coordination or FunctionSlovenia
-
Hospital de Clinicas de Porto AlegreYale UniversityUnknownAttention-deficit/Hyperactivity Disorder.Brazil
-
Universidade Federal do Rio de JaneiroUnknown